| Jul 30 |
Syros Pharmaceuticals Q2 2024 Earnings Preview
|
| Jul 24 |
Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
|
| Jul 17 |
Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why
|
| Jul 2 |
Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout
|
| Jun 17 |
Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week
|
| Jun 13 |
Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression
|
